Amarin Corp Plc (AMRN)

[couldbebetter]

xblkbk, With as massive of a market opportunity as Vascepa has for
Europe, it could not be optimized without the involvement of BP
as either a JV partner or through a BO. From JT's conference call
it sounds like he laying the groundwork for BP involvement when
the time is "ripe." The person JT selected to lead this effort
most likely knows how BP would want Europe to set up and Vascepa
prices appropriately for them to swoop in and take over. Europe
should have enough potential value to justify a "robust" BO offer,
especially since Vascepa should become the go to drug for people
who have elevated systemic inflammation as a result of having
had COVID-19.

Should AMRN lose with the court of appeals the BP owner would simply
concentrate on those markets that have patent/IP protection...and
if it were to make economic sense, provide a branded generic if the
BP were set up to do so.

Most encouraging to see an analyst suggest that Vascepa has a
potentially massive market in Europe.